中国寄生虫学与寄生虫病杂志 ›› 2012, Vol. 30 ›› Issue (6): 6-442-445.

• 论著 • 上一篇    下一篇

用多肽-蛋白偶联方法制备抗恶性疟原虫抗体

钱锋   

  1. 第二军医大学长征医院风湿免疫科,上海 200003
  • 出版日期:2012-12-31 发布日期:2013-02-05

Preparation of Anti-malaria Antibodies with  a Way of Peptide-protein Conjugation

QIAN Feng   

  1. Department of Rheumatology and Immunology, Changzheng Hospital, The Second Military Medical University, Shanghai 200003, China
  • Online:2012-12-31 Published:2013-02-05

摘要: 目的  介绍一种多肽-蛋白偶联的流程,并用多肽-蛋白偶联产物制备抗疟原虫抗体。  方法  用化学连接剂Sulfo-EMCS在作为载体蛋白的铜绿假单胞菌重组去毒外毒素(rEPA)上加马来酰亚胺基团,用间接Ellman反应测定载体蛋白上所加的马来酰亚胺基团数量。用马来酰亚胺修饰的载体蛋白滴定Pfs48/45-158多肽[含恶性疟原虫表面蛋白48/45(Pfs48/45)第158~173氨基酸序列,其N末端带有一个半胱氨酸残基],绘制滴定曲线并用线性回归进行曲线拟合,根据滴定曲线确定理论滴定终点,计算多肽与载体蛋白的偶联比(每摩尔载体蛋白所能结合的多肽的摩尔数)。用过量的Pfs48/45-158多肽与马来酰亚胺修饰的rEPA进行反应,规模制备Pfs48/45?鄄158-rEPA多肽-蛋白偶联物,偶联物用十二烷基硫酸钠-聚丙烯酰胺凝胶电泳(SDS-PAGE)进行鉴定。用所制备的Pfs48/45-158-rEPA偶联物免疫BALA/c小鼠,制备免疫血清。用ELISA测定免疫小鼠血清抗Pfs48/45-158多肽的抗体效价,用免疫荧光试验(IFA)测定免疫血清识别疟原虫的能力。  结果  通过化学连接剂在每摩尔rEPA上添加约6.94摩尔的马来酰亚胺基团。制备了偶联比约为7.33的Pfs48/45-158-rEPA多肽-蛋白偶联物。偶联物免疫小鼠激发出抗Pfs48/45-158多肽的高抗体应答,免疫血清抗Pfs48/45-158多肽的效价为12 500 ELISA单位(即吸光度A405值为1时的血清稀释度倒数),同时免疫血清可识别疟原虫。  结论  多肽-蛋白偶联是一种可用于制备抗疟原虫抗体的便捷方法,间接Ellman检测、滴定反应和SDS-PAGE分析构成了多肽-蛋白偶联物制备的质控方法,可更好地保证多肽-蛋白偶联物的质量和稳定性。

关键词: 多肽, 化学偶联, 抗体, 疟疾

Abstract: Objective   To introduce a procedure of peptide-protein conjugation and prepare anti-malaria antibodies using a peptide-protein conjugate.  Methods  The recombinant atoxic form of Pseudomonas aeruginosa exotoxin A (rEPA) was used as carrier protein and modified by maleimide groups using the chemical linker of Sulfo-EMCS. The number of the maleimide group added onto the protein was measured by indirect Ellman’s reaction. The maleimide modified protein was used to titrate the Pfs48/45-158, a synthetic peptide including a short amino acid sequence of Plasmodium falciparum Pfs48/45 with a cysteine residue at its N-terminus, and the curve fitting of the titration data was performed using linear regression. Based on the titration curve, the theoretic titration end point was determined and the conjugation ratio of peptide to carrier protein (mole peptide per mole carrier protein) was calculated. To scale up the preparation of the peptide-protein conjugate of Pfs48/45-158-rEPA, the peptide was used in excess to react with the modified carrier protein, and the resulting product was examined by SDS-PAGE. BALB/c mice were immunized with the peptide-protein conjugates. The mouse immune sera were examined by  ELISA and immunofluorescence assay (IFA), two assays used respectively to determine the antibody titers against the peptide and the ability of the sera to recognize malaria parasites.  Results  About 6.94 moles of maleimide groups were added onto one mole of rEPA via the chemical linker used in the reaction. The peptide-protein conjugate of Pfs48/45-158-rEPA was prepared with a conjugation ratio being about 7.33. High antibody titers against the Pfs48/45-158 peptide (12 500 ELISA units) were induced in mice immunized with the conjugates. The mouse immune sera were able to recognize not only the peptide but also the malaria parasites.  Conclusion  Peptide-protein conjugation is a convenient way that can be used to prepare anti-malaria antibodies. The indirect Ellman’s rection, titration and SDS-PAGE used in the study form a set of quality control methods, which ensures the quality and reproducibility of the conjugate.

Key words: Peptide, Chemical conjugation, Antibody, Malaria